Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in serum from patients comedicated with other psychotropic drugs

This publication has 10 references indexed in Scilit:

• Therapeutic Drug Monitoring Databases for Postmarketing Surveillance of Drug-Drug Interactions
  Therapeutic Drug Monitoring, 1997
• Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man
  Psychopharmacology, 1995
• Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography
  Brain Research, 1993
• Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations
  Acta Psychiatrica Scandinavica, 1993
• Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1993
• Determination of Risperidone in Plasma by High-Performance Liquid Chromatography with Electrochemical Detection: Application to Therapeutic Drug Monitoring in Schizophrenic Patients
  Journal of Pharmaceutical Sciences, 1993
• A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients
  Journal of Clinical Psychopharmacology, 1993
• Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects
  Clinical Pharmacology & Therapeutics, 1993
• Determination of risperidone and 9-hydroxyrisperidone in plasma, urine and animal tissues by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1992
• Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study
  Acta Psychiatrica Scandinavica, 1992